Insilico Medicine Cayman TopCo

Biotechnology company · Hong Kong, Hong Kong SAR China

Insilico Medicine Cayman TopCo is a biotechnology company headquartered in Hong Kong, Hong Kong SAR China. Its earliest recorded incorporation is in 2019. It has reported private securities offerings to the US SEC, most recently $37 million sold in a notice filed in 2019.

Profile compiled from public records. Is this your company? Request a correction or update

Insilico Medicine Cayman TopCo at a glance

Typebiotechnology company

HeadquartersHong Kong, Hong Kong SAR China

Earliest incorporation on record2019

SEC CIK1789097

What does Insilico Medicine Cayman TopCo do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $36.8 million sold (2019).

Frequently asked questions about Insilico Medicine Cayman TopCo

Where is Insilico Medicine Cayman TopCo headquartered?

Insilico Medicine Cayman TopCo is headquartered in Hong Kong, Hong Kong SAR China.

What does Insilico Medicine Cayman TopCo do?

Insilico Medicine Cayman TopCo is a biotechnology company.

When was Insilico Medicine Cayman TopCo founded?

The earliest incorporation on record for Insilico Medicine Cayman TopCo is in 2019, according to public company registers.

Similar companies

Global Eagle China Life Technology Co.,LimitedHong Kong, Hong Kong SAR China

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Last updated 2026-09-23. Data licences